101 related articles for article (PubMed ID: 20531244)
1. Alterations in gene expression in MEN1-associated insulinoma development.
Serewko-Auret MM; Mould AW; Loffler KA; Duncan R; Kay GF; Hayward NK
Pancreas; 2010 Nov; 39(8):1140-6. PubMed ID: 20531244
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
3. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Lejonklou MH; Barbu A; Stålberg P; Skogseid B
Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
[TBL] [Abstract][Full Text] [Related]
6. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
7. Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells.
Lejonklou MH; Edfeldt K; Johansson TA; Stålberg P; Skogseid B
Pancreas; 2009 Apr; 38(3):259-66. PubMed ID: 19307926
[TBL] [Abstract][Full Text] [Related]
8. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
9. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
10. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
11. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
[TBL] [Abstract][Full Text] [Related]
12. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
13. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
[TBL] [Abstract][Full Text] [Related]
16. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
Fontanière S; Casse H; Bertolino P; Zhang CX
Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors.
Lindberg D; Hessman O; Akerström G; Westin G
Neuroendocrinology; 2007; 86(2):112-8. PubMed ID: 17664862
[TBL] [Abstract][Full Text] [Related]
18. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
[TBL] [Abstract][Full Text] [Related]
19. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
[TBL] [Abstract][Full Text] [Related]
20. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells.
Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T
Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
